Product Highlight - Valganciclovir hydrochloride (Valvir-450)

10 Jun 2025
Product Highlight - Valganciclovir hydrochloride (Valvir-450)

A convenient approach to combat CMV

  • Valganciclovir is indicated for the induction and maintenance treatment of cytomegalovirus (CMV) retinitis in patients with acquired immunodeficiency syndrome (AIDS).1
  • Valganciclovir is indicated for the prevention of CMV disease in CMV-negative patients who have received a solid organ transplant from a CMV-positive donor.1

Reference:
1. Product Information of Valvir-450 – February 2020



CAMBER PHARMACEUTICALS INC.
Unit 2104-2105 21st Flr, The Pearl Bank Ctr
146 Valero St, Salcedo Vill, Makati City
Phone: (+63-2) 5322 9000

Related MIMS Drugs